evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract
5769,GENE_BACKGROUND,,"BAP1 (BRCA-associated Protein-1) is a nuclear ubiquitin hydrolase that has been implicated in several cellular processes including cell proliferation, DNA repair, chromatin regulation of gene expression, and stem cell pluripotency (PMID: 19815555, 20805357, 18757409). By deubiquitinating host cell factor-1 (HCF-1), a chromatin-associated protein that helps regulate transcription, BAP1 regulates cell proliferation (PMID: 19815555). BAP1 has been shown to regulate gene expression by forming a ternary complex with HCF-1 and the YY1 transcription factor (PMID: 20805357) and to enhance cell death by increasing progression through the G1-S checkpoint (PMID: 18757409). BAP1 loss alters class I histone deacetylase (HDAC) expression, which may result in altered therapeutic response to HDAC inhibitors in BAP1-depleted cancer cells (PMID: 25970771). Germline mutations of BAP1 predispose to several tumors including renal cell carcinoma, uveal melanoma and mesothelioma, which suggests that BAP1 is a tumor suppressor (PMID:23277170, 21874000, 23849051). Somatic BAP1 mutations are also common in these tumor types, among others (PMID: 23867514, 21642991, 23277170).",,2017-10-18,,8314,BAP1,BRCA1 associated protein 1,False,ENST00000460680,NM_004656.3,HUCEP-13,hucep-6,True,19815555,The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1.,The Journal of biological chemistry,2017-12-04T20:09:00,284,49,34179-88,Machida YJ et al,doi: 10.1074/jbc.M109.046755,,0001-12-04,,25970771,Loss of the deubiquitylase BAP1 alters class I histone deacetylase expression and sensitivity of mesothelioma cells to HDAC inhibitors.,Oncotarget,2018-05-30T20:15:00,6,15,13757-71,Sacco JJ et al,,,0001-05-30,,18757409,BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization.,Cancer research,2018-09-01T20:08:00,68,17,6953-62,Ventii KH et al,doi: 10.1158/0008-5472.CAN-08-0365,,0001-09-01,,23277170,Tumours associated with BAP1 mutations.,Pathology,2018-02-01T20:13:00,45,2,116-26,Murali R et al,doi: 10.1097/PAT.0b013e32835d0efb,,0001-02-01,,21874000,Germline BAP1 mutations predispose to malignant mesothelioma.,Nature genetics,2018-08-28T20:11:00,43,10,1022-5,Testa JR et al,doi: 10.1038/ng.912,,0001-08-28,,21642991,The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma.,Nature genetics,2018-06-05T20:11:00,43,7,668-72,Bott M et al,doi: 10.1038/ng.855,,0001-06-05,,20805357,The ubiquitin carboxyl hydrolase BAP1 forms a ternary complex with YY1 and HCF-1 and is a critical regulator of gene expression.,Molecular and cellular biology,2018-11-01T20:10:00,30,21,5071-85,Yu H et al,doi: 10.1128/MCB.00396-10,,0001-11-01,,23849051,Further evidence for germline BAP1 mutations predisposing to melanoma and malignant mesothelioma.,Cancer genetics,2018-05-01T20:13:00,206,5,206-10,Cheung M et al,doi: 10.1016/j.cancergen.2013.05.018,,0001-05-01,,23867514,PBRM1 and BAP1 as novel targets for renal cell carcinoma.,"Cancer journal (Sudbury, Mass.)",2018-07-01T20:13:00,19,4,324-32,Brugarolas J,doi: 10.1097/PPO.0b013e3182a102d1,,0001-07-01,
5768,GENE_SUMMARY,,"BAP1 is a tumor suppressor and deubiquitinating enzyme. Germline mutations of BAP1 predispose to various cancers, including malignant mesothelioma, uveal and cutaneous melanoma, and renal cell carcinoma.",,2017-10-23,,8314,BAP1,BRCA1 associated protein 1,False,ENST00000460680,NM_004656.3,HUCEP-13,hucep-6,True,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
